Skip to main content
Gynecologic Cancer Breast Cancer

Breast Cancer

Open Access Cancer Therapy Review

ADCs in cancer: key data for currently approved agents

Delve into the efficacy and safety data for the antibody–drug conjugates currently approved by the US FDA across tumor types such as hematologic, genitourinary, and gynecologic cancers.

Forgoing axillary surgery does not increase breast cancer recurrence

04-04-2024 Breast Cancer News

Completion axillary lymph node dissection can be avoided in patients with early-stage, node-negative breast cancer with one or two macrometastases, show phase 3 data.

Ovarian suppression in breast cancer

Open Access Breast Cancer Review

Ovarian function suppression plays a key role in the management of breast cancer, but it comes with potentially impactful and long-lasting side effects. Counselling and proactive management of these should be considered an essential part of survivorship care.

Doxorubicin use may increase breast cancer risk in adult Hodgkin’s lymphoma survivors

20-03-2024 Hodgkin Lymphoma News

Adolescent and adult survivors of Hodgkin’s lymphoma have a higher risk for developing breast cancer if they receive doxorubicin than if they do not.

Integrated care in breast cancer

Open Access Breast Cancer Review

A holistic approach that takes into account all aspects of patient care – from treatment to nutrition, physical activity, and rehabilitation – could be a powerful tool to improve survival and quality of life in breast cancer. 

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine

Case Studies

A rare, late side effect of radiotherapy

Open Access Breast Cancer Case Study

A woman developed sudden painless ecchymosis (bruising) of her breast, which was thought to be related to the radiotherapy she received for early-stage breast cancer a year and a half earlier.

Breast metastases in a male patient with nasopharyngeal carcinoma

Open Access Nasopharyngeal Cancer Case Study

Nasopharyngeal carcinoma is known for its high potential to metastasize, but breast metastasis is rare. The authors describe the first case of synchronous breast metastases in a male patient.

HER2-positive mucoepidermoid carcinoma of the breast

Open Access Breast Cancer Case Study

Mucoepidermoid carcinoma of the breast is a rare type of salivary gland-like tumor that generally displays a triple-negative phenotype. This case is the first to demonstrate HER2 gene amplification.

Current Reviews

The future of clinical trials—goals, ideas, and discussion

Open Access Breast Cancer review

Clinical trials are subject to an ever-evolving landscape of treatment options, regulatory requirements, socioeconomic conditions, and paradigms of scientific research. In this opinion paper, we illustrate current methods and topics with a focus …

Ultrasound-based radiomics for early predicting response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review with meta-analysis

Breast Cancer Oncology Imaging

Breast cancer is the most common neoplasm for women worldwide, and it is a crucial threat to the health of women [ 1 ]. With the renewal of breast cancer treatment concepts, neoadjuvant chemotherapy (NAC) has now become a crucial component of …

PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer

Open Access Breast Cancer Review Article

Triple-negative breast cancer (TNBC) is a highly heterogeneous tumor lacking estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. It has higher aggressiveness and metastasis than other …

Exploring the potential of machine learning in gynecological care: a review

Gynecological health remains a critical aspect of women’s overall well-being, with profound implications for maternal and reproductive outcomes. This comprehensive review synthesizes the current state of knowledge on four pivotal aspects of …

Case-Based Insights: Oncology and Hematology (Link opens in a new window)


Refresh your knowledge in Oncology and Hematology: 

  • 45 clinical cases across different topics with relevant clinical images
  • Written by renowned experts 
  • Knowledge-check questions with answers
Try the first set of cases now

eLearning | Interviews | Cases (Link opens in a new window)

0.75 AMA PRA Category 1 Credit(s)

Knowledge center focusing on improving the individualized management of HR+/HER2- early breast cancer.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Webinar | 16-05-2023 | 17:30 (CEST)

Keynote webinar | Spotlight on cardio-oncology

An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.

Prof. Rudolf de Boer
Prof. Lorenz Lehmann
Dr. Teresa Lopéz Fernández
Developed by: Springer Medicine

Further Reading

Sentinel lymph node biopsy before and after neoadjuvant chemotherapy in cN0 breast cancer patients: impact on axillary morbidity and survival—a propensity score cohort study

Open Access Breast Cancer Research

Sentinel lymph node biopsy (SLNB) has been proven equally safe and accurate compared to axillary lymph node dissection (ALND) [ 1 , 2 ] when evaluating axillary status in cN0 patients, while also benefiting from less morbidity and better quality of …

French national survey on breast cancer care: caregiver and patient views

Open Access Breast Cancer Original Article

Worldwide, breast cancer ranks first among cancers in women regarding both incidence and mortality [ 1 ].

The future of clinical trials—goals, ideas, and discussion

Open Access Breast Cancer review

Clinical trials are subject to an ever-evolving landscape of treatment options, regulatory requirements, socioeconomic conditions, and paradigms of scientific research. In this opinion paper, we illustrate current methods and topics with a focus …

Ambient polycyclic aromatic hydrocarbon exposure and breast cancer risk in a population-based Canadian case–control study

Open Access Breast Cancer Original Paper

The global incidence of female breast cancer is rising [ 1 , 2 ], and in 2020, among women, breast cancer surpassed lung cancer in the number of incident cases reported worldwide [ 1 , 3 ]. In Canada, breast cancer is the most commonly diagnosed …